BACKGROUND: The objective of this study was to confirm whether an association between handedness and the side of symptom onset exists and to evaluate the impact of this association on specific clinical characteristics of Parkinson's disease (PD). METHODS: 1173 PD patients were identified from a clinical database. Patients with asymmetrical onset (n=1015) were divided into those with dominant-side onset and those with non-dominant-side onset, and the clinical characteristics of the two subgroups were compared. RESULTS: In our PD sample, 86.5% of patients presented asymmetrically. There was a significant association between handedness and the side of the initial symptom; that is, the dominant side was affected first in the majority of both left- and right-handed patients. Compared with patients with non-dominant side onset, more patients with dominant-side onset presented with bradykinesia, while fewer patients presented with gait difficulty. Patients with dominant-side onset were diagnosed and began dopaminergic medication after a longer symptom duration than patients with non-dominant-side onset. The only difference in Unified Parkinson Disease Rating Scale scores between the two groups was in a subscore addressing dominant-hand tasks. CONCLUSIONS: An association exists between the dominant hand and the side of the initial motor symptom in PD. Whether the initial symptom occurs on the dominant or non-dominant side has implications for the reported first symptom, the time to diagnosis and the time to dopaminergic treatment initiation. The side of disease onset does not affect the severity of disease, as measured by the Unified Parkinson Disease Rating Scale.
BACKGROUND: The objective of this study was to confirm whether an association between handedness and the side of symptom onset exists and to evaluate the impact of this association on specific clinical characteristics of Parkinson's disease (PD). METHODS: 1173 PDpatients were identified from a clinical database. Patients with asymmetrical onset (n=1015) were divided into those with dominant-side onset and those with non-dominant-side onset, and the clinical characteristics of the two subgroups were compared. RESULTS: In our PD sample, 86.5% of patients presented asymmetrically. There was a significant association between handedness and the side of the initial symptom; that is, the dominant side was affected first in the majority of both left- and right-handed patients. Compared with patients with non-dominant side onset, more patients with dominant-side onset presented with bradykinesia, while fewer patients presented with gait difficulty. Patients with dominant-side onset were diagnosed and began dopaminergic medication after a longer symptom duration than patients with non-dominant-side onset. The only difference in Unified Parkinson Disease Rating Scale scores between the two groups was in a subscore addressing dominant-hand tasks. CONCLUSIONS: An association exists between the dominant hand and the side of the initial motor symptom in PD. Whether the initial symptom occurs on the dominant or non-dominant side has implications for the reported first symptom, the time to diagnosis and the time to dopaminergic treatment initiation. The side of disease onset does not affect the severity of disease, as measured by the Unified Parkinson Disease Rating Scale.
Authors: J Green; W M McDonald; J L Vitek; M Evatt; A Freeman; M Haber; R A E Bakay; S Triche; B Sirockman; M R DeLong Journal: Neurology Date: 2002-11-12 Impact factor: 9.910
Authors: Allison A Bay; Ariel R Hart; W Michael Caudle; Daniel M Corcos; Madeleine E Hackney Journal: J Neurol Sci Date: 2018-12-04 Impact factor: 3.181
Authors: Mechelle M Lewis; Nicholas W Sterling; Guangwei Du; Eun-Young Lee; Grace Shyu; Michael Goldenberg; Thomas Allen; Christy Stetter; Lan Kong; Shedra Amy Snipes; Byron C Jones; Honglei Chen; Richard B Mailman; Xuemei Huang Journal: Toxicol Sci Date: 2017-09-01 Impact factor: 4.849
Authors: Zheng Zhong; Douglas Merkitch; M Muge Karaman; Jiaxuan Zhang; Yi Sui; Jennifer G Goldman; Xiaohong Joe Zhou Journal: Radiology Date: 2019-02-19 Impact factor: 11.105
Authors: Jan Štochl; Tim J Croudace; Hana Brožová; Jiří Klempíř; Jan Roth; Evžen Růžička Journal: J Neural Transm (Vienna) Date: 2012-01-10 Impact factor: 3.575
Authors: Michael T Barbe; Martin Amarell; Anke H Snijders; Esther Florin; Eva-Lotte Quatuor; Eckhard Schönau; Gereon R Fink; Bastiaan R Bloem; Lars Timmermann Journal: J Neurol Date: 2013-12-04 Impact factor: 4.849